Literature DB >> 11388517

An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador.

S R Manock1, P M Kelley, K C Hyams, R Douce, R D Smalligan, D M Watts, T W Sharp, J L Casey, J L Gerin, R Engle, A Alava-Alprecht, C M Martínez, N B Bravo, A G Guevara, K L Russell, W Mendoza, C Vimos.   

Abstract

An outbreak of delta hepatitis occurred during 1998 among the Waorani of the Amazon basin of Ecuador. Among 58 people identified with jaundice, 79% lived in four of 22 Waorani communities. Serum hepatitis B surface antigen (HBsAg) was found in the sera of 54% of the jaundiced persons, and 14% of asymptomatic persons. Ninety-five percent of 105 asymptomatic Waorani had hepatitis B core (HBc) IgG antibody, versus 98% of 51 with jaundice. These data confirm that hepatitis B virus (HBV) infection is highly endemic among the Waorani. Sixteen of 23 (70%) HBsAg carriers identified at the onset of the epidemic had serologic markers for hepatitis D virus (HDV) infection. All 16 were jaundiced, where as only two of seven (29%) with negative HDV serology were jaundiced (P = .0006). The delta cases clustered in families, 69% were children and most involved superinfection of people chronically infected with HBV. The data suggest that HDV spread rapidly by a horizontal mode of transmission other than by the sexual route.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11388517     DOI: 10.4269/ajtmh.2000.63.209

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  13 in total

1.  The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2006-06-21       Impact factor: 4.942

2.  The fraction of RNA that folds into the correct branched secondary structure determines hepatitis delta virus type 3 RNA editing levels.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2009-04-21       Impact factor: 4.942

3.  Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.

Authors:  Lauren M Kucirka; Homayoon Farzadegan; Jordan J Feld; Shruti H Mehta; Mark Winters; Jeffrey S Glenn; Gregory D Kirk; Dorry L Segev; Kenrad E Nelson; Morgan Marks; Theo Heller; Elizabeth T Golub
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

4.  Five-Year Eradication of Hepatitis B Infection After an Outreach Immunization Program in the Waorani Population in the Ecuadorian Amazon.

Authors:  Edy Quizhpe; Gladys Ñauta; Juan Antonio Córdoba-Doña; Enrique Teran
Journal:  Am J Trop Med Hyg       Date:  2016-07-05       Impact factor: 2.345

5.  A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.

Authors:  Bruno B Bordier; Patricia L Marion; Kazuo Ohashi; Mark A Kay; Harry B Greenberg; John L Casey; Jeffrey S Glenn
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Treatment options for hepatitis delta virus infection.

Authors:  Benjamin Heidrich; Michael P Manns; Heiner Wedemeyer
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

7.  Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon.

Authors:  Márcia da Costa Castilho; Cintia Mara Costa de Oliveira; João Bosco de Lima Gimaque; Jorge Di Tommaso Leão; Wornei Silva Miranda Braga
Journal:  Am J Trop Med Hyg       Date:  2012-08-20       Impact factor: 2.345

8.  RNA editing in hepatitis delta virus genotype III requires a branched double-hairpin RNA structure.

Authors:  John L Casey
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 9.  Sexually acquired hepatitis.

Authors:  M G Brook
Journal:  Sex Transm Infect       Date:  2002-08       Impact factor: 3.519

10.  Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia.

Authors:  Diana di Filippo Villa; Fabian Cortes-Mancera; Edra Payares; Neyla Montes; Fernando de la Hoz; Maria Patricia Arbelaez; Gonzalo Correa; Maria-Cristina Navas
Journal:  Virol J       Date:  2015-10-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.